Fluticasone Propionate

HCID 444036

기본 정보

CAS
80474-14-2
표준 SMILES
CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
InChIKey
WMWTYOKRWGGJOA-CENSZEJFSA-N
분자식
C25H31F3O5S
평균 분자량
500.6 g/mol
단동위원소 질량
500.18442975

개요

Fluticasone Propionate can cause developmental toxicity according to state or federal government labeling requirements.

이름 및 식별자

우선 이름
Fluticasone Propionate
IUPAC
[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
영어명
Fluticasone propionate
분자식
C25H31F3O5S
분자량
500.57

이름 및 동의어

FLUTICASONE PROPIONATE80474-14-2FloventCutivateFlixotideFlonaseFlovent HFAFlovent DiskusFlovent Diskus 50Flovent Diskus 100Flovent Diskus 250Xhance
이름 더 보기
Fluticasone propionate for impurity C identification CRSFluticasone propionate for impurity C identificationZoflutflutideFLUNASEFLIXONASE
CCI-18781ArmonAir RespiClickCCI 18781DTXSID8045511Fluticasone-17-propionateO2GMZ0LF5Wcci18781Flonase Allergy Relief

데이터베이스 식별자

CAS
80474-14-2
PubChem CID
444036
DTXSID
DTXSID8045511
ChEMBL
CHEMBL1473
ChEBI
CHEBI:31441
UNII
O2GMZ0LF5W
EC Number
617-082-4
Nikkaji
J457.058H

물성

구조 계산 물성

XLogP
4
극성 표면적
106 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
9
회전 가능 결합 수
6
무거운 원자 수
34

실험 및 물리화학적 성질

Drugs · 2건

Pharmaceuticals -> Dermatologicals -> Corticosteroids, dermatological preparations

Pharmaceuticals -> Listed in ZINC15

SolubilityInsoluble
Human Drugs · 3건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Pharmaceuticals

Endocrine DisruptorsPotential endocrine disrupting compound
Melting Point261-273 °C
Physical DescriptionSolid

물리화학적 성질

녹는점
275 °C · 275 °C
끓는 점
568.3 · 568.3±50.0 °C(Predicted)
밀도
1.32 · 1.32±0.1 g/cm3(Predicted)
굴절률
31 ° · 31 ° (C=1, Dioxane)
저장 조건
Store at RT
용해도
10 mg/mL · DMSO: ≥10 mg/mL
화학적 성질 · 1건

Fluticasone propionate is a white to off-white powder with a molecular weight of 500.6, and 17 the empirical formula is C25H31F3O5S. It is practically insoluble in water, freely soluble in 18 dimethyl sulfoxide and dimethylformamide, and slightly soluble in methanol and 95% ethanol.

안전 및 규제

GHS 분류

GHS Classification · 5건

This chemical does not meet GHS hazard criteria for 10% (2 of 20) of reports.

Danger

H302 (20%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P233, P260, P261, P264, P270, P271, P272, P273, P280, P284, P301+P317, P302+P352, P304+P340, P318, P319, P321, P330, P333+P317, P342+P316, P362+P364, P391, P403, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 20 reports by companies from 17 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory Information · 2건

Hazard Traits - Developmental Toxicity

Fluticasone propionate: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and CategoriesAcute Tox. 4 (20%)

안전 데이터

wgk
2
rtecs
BV7980000
독성
LD50 oral in rat: > 2gm/kg
HS 번호
29372900
safety_code
22-24/25
Hazard Classifications
Repr. 2STOT RE 2

화학 및 산업

약리 정보

Protein BindingFluticasone propionate is 99% protein bound in serum. Topical fluticasone propionate is only 91% protein bound in serum however.
PharmacodynamicsSystemically, fluticasone propionate activates glucocorticoid receptors, and inhibits lung eosinophilia in rats. Fluticasone propionate as a topical formulation is also associated with vasoconstriction in the skin.
Mechanism of ActionFluticasone propionate works through an unknown mechanism to affect the action of various cell types and mediators of inflammation. Fluticasone propionate activates glucocorticoid receptors and inhibits lung eosinophilia in rats.
Biological Half-Life7.8 hours for intravenous fluticasone propionate. A study of 24 healthy Caucasian males shows a half life of 14.0 hours following intravenous administration and 10.8 hours following inhalation.
Metabolism/MetabolitesFluticasone propionate is cleared from hepatic metabolism by cytochrome P450 3A4. Fluticasone propionate is hydrolysed at the FIVE-S-fluoromethyl carbothioate group, forming an inactive metabolite.
FDA Pharmacological Classification · 6건

FLUTICASONE PROPIONATE

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

ALLERGY RELIEF NASAL

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

FLUTICASONE PROPIONATE NASAL

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

용도 및 제조

Use ClassificationPharmaceuticals
응용 분야 · 2건

용도Fluticasone Propionate is a derivative of Flumethasone, a glucocorticoid that has antiallergic, anti-asthmatic, and anti-inflammatory properties. It is used in the treatment of seasonal rhinitis and asthma. Compared to beclomethasone dipropionate, fluticasone propionate is reported to have a comparable side effect profile, but twice the activity in the treatment of asthma.

일반 설명Fluticasone Propionate is the propionate salt form of fluticasone, a synthetic trifluorinated glucocorticoid receptor agonist with antiallergic, antiinflammatory and antipruritic effects. Binding and activation of the glucocorticoid receptor results in the activation of lipocortin that in turn inhibits cytosolic phospholipase A2, which triggers cascade of reactions involved in synthesis of inflammatory mediators, such as prostaglandins and leukotrienes. Secondly, mitogen-activated protein kinase (MAPK) phosphatase 1 is induced, thereby leads to dephosphorylation and inactivation of Jun N-terminal kinase directly inhibiting c-Jun mediated transcription. Finally, transcriptional activity of nuclear factor (NF)-kappa-B is blocked, thereby inhibits the transcription of cyclooxygenase 2, which is essential for prostaglandin production.

제조 방법 · 1건

Fluticasone propionate, synthesized by Glaxo Wellcome and launched in 1993, is a trifluorinated glucocorticosteroid. It shows good topical antiinflammatory activity and is commonly used as a safe and effective inhaled treatment for asthma and allergic rhinitis.Fluticasone propionate can be synthesized from 9 by using BrCH2F,2a ClCH2F,5a or S-(monofluoromethyl) diarylsulfonium tetrafluoroborate 5f,g directly. Using BrCH2F can get an ideal yield; however, BrCH2F is costly and will destroy to the ozone layer. In addition, 9 reacted with BrCH2Cl or Br2CH2 and then by an anion exchange with AgF,2c,5e KF, or tetrabutylammonium fluoride5b to afford 1 in a low yield.Improved Synthesis of Fluticasone Propionate

공급사100 곳

国药集团化学试剂有限公司86-21-63210123 · [email protected]
北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
广州佳途科技股份有限公司81960175 18933936954 · [email protected]
추가 설명 · 1건

정의ChEBI: Fluticasone propionate is a trifluorinated corticosteroid that consists of 6alpha,9-difluoro-11beta,17alpha-dihydroxy-17beta-{[(fluoromethyl)sulfanyl]carbonyl}-16-methyl-3-oxoandrosta-1,4-diene bearing a propionyl substituent at position 17; has anti-inflammatory, anti-asthmatic and anti-allergic activity. It has a role as an anti-allergic agent, an anti-asthmatic drug, an anti-inflammatory drug, a dermatologic drug, a bronchodilator agent and an adrenergic agent. It is a corticosteroid, a steroid ester, an 11beta-hydroxy steroid, a propanoate ester, a fluorinated steroid, a thioester and a 3-oxo-Delta(1),Delta(4)-steroid. It derives from a fluticasone. It derives from a hydride of an androstane.

관련 반응

4건

화합물 노트

불러오는 중…